New Key Statistics Module, Z-Score and F-Score
NYSE:ABT Key Ratios
Market Cap $ M | 198,265.66 |
Enterprise Value $ M | 205,549.90 |
P/E(ttm) | 34.74 |
PE Ratio without NRI | 25.29 |
Forward PE Ratio | 22.14 |
Price/Book | 4.98 |
Price/Sales | 4.85 |
Price/Free Cash Flow | 30.80 |
Price/Owner Earnings | 40.24 |
Payout Ratio % | 0.48 |
Revenue (TTM) $ M | 41,217.00 |
EPS (TTM) $ | 3.29 |
Beneish M-Score | -2.66 |
10-y EBITDA Growth Rate % | 11.80 |
5-y EBITDA Growth Rate % | 11.50 |
y-y EBITDA Growth Rate % | 5.30 |
EV-to-EBIT | 27.93 |
EV-to-EBITDA | 19.42 |
PEG | 2.20 |
Shares Outstanding M | 1,734.46 |
Net Margin (%) | 13.99 |
Operating Margin % | 16.24 |
Pre-tax Margin (%) | 16.45 |
Quick Ratio | 1.14 |
Current Ratio | 1.60 |
ROA % (ttm) | 7.90 |
ROE % (ttm) | 14.86 |
ROIC % (ttm) | 10.65 |
Dividend Yield % | 1.92 |
Altman Z-Score | 5.23 |
ABT Number of Guru Trades
ABT Volume of Guru Trades
Gurus Latest Trades with NYSE:ABT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:ABT is held by these investors
Total 7
Abbott Laboratories Insider Transactions
No Available Data
News about NYSE:ABT
Total 0- 1